Curis (CRIS) Equity Average (2011 - 2026)
Curis (CRIS) reported Equity Average of $9.1 million for Q1 2026, up 244.14% on a YoY basis from $2.6 million in Q1 2025, and up 296.87% quarter-over-quarter from -$4.6 million in Q4 2025.
Curis (CRIS) Equity Average (2011 - 2026) Analysis & Trends
Curis has reported Equity Average for 16 years, with the latest figure at $9.1 million in Q1 2026.
- For the quarter ending Q1 2026, Equity Average rose 244.14% year-over-year to $9.1 million; the trailing twelve-month figure through Mar 2026 stood at $9.1 million (up 244.14% YoY), and the FY2025 full-year result was -$268000.0, down 103.92% from the prior year.
- Equity Average for Q1 2026 stood at $9.1 million, up from -$4.6 million in the prior quarter.
- The five-year high for Equity Average was $83.3 million in Q1 2022, with the low at -$14.3 million in Q3 2025.
- Historically, Equity Average has averaged $21.7 million across 5 years, with a median of $14.6 million in 2024.
- Annual changes were most pronounced in 2025 — Equity Average plunged 334.87% — and 2026, when it soared 244.14%.
- Curis' Equity Average stood at $51.1 million in 2022, then sank by 51.85% to $24.6 million in 2023, then sank by 129.91% to -$7.4 million in 2024, then surged by 37.36% to -$4.6 million in 2025, then surged by 296.87% to $9.1 million in 2026.
- The last three Equity Average figures came in at $9.1 million (Q1 2026), -$4.6 million (Q4 2025), and -$14.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | 3.50 Bn |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | 783.14 Mn |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 3.76 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 1.01 Bn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 21.35 Mn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 19.01 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 516.41 Mn |
| 10 | Curis | 8.58 Mn | -6.42 Mn | - | 9.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.08 Mn |
| Dec 31, 2025 | -4.61 Mn |
| Sep 30, 2025 | -14.34 Mn |
| Jun 30, 2025 | -10.30 Mn |
| Mar 31, 2025 | -6.30 Mn |
| Dec 31, 2024 | -7.37 Mn |
| Sep 30, 2024 | -4.71 Mn |
| Jun 30, 2024 | 4.38 Mn |
| Mar 31, 2024 | 14.57 Mn |
| Dec 31, 2023 | 24.63 Mn |
| Sep 30, 2023 | 27.91 Mn |
| Jun 30, 2023 | 31.41 Mn |
| Mar 31, 2023 | 41.57 Mn |
| Dec 31, 2022 | 51.15 Mn |
| Sep 30, 2022 | 58.90 Mn |
| Jun 30, 2022 | 69.01 Mn |
| Mar 31, 2022 | 83.34 Mn |
| Dec 31, 2021 | 96.81 Mn |
| Sep 30, 2021 | 107.69 Mn |
| Jun 30, 2021 | 117.19 Mn |